Darmstadt, Germany 12/10/15—At its 2015 Capital Market Day, Merck KGaA provided details about its merger with Sigma-Aldrich (see IBO 11/30/15) and how it plans to realize the €260 million ($286 million = €0.91 = $1) in synergies by 2018. Merck Life Science now consists of Research Solutions, representing 35% of revenues; Process Solutions, which make […]
Published this month by the European Commission (EC), the 2015 EU Industrial R&D Scoreboard tracked the spending of 2,500 publicly held companies in 44 countries across 41 industries that are the world’s largest R&D spenders. Together, these companies represented an estimated 90% of global business R&D and 55% of total R&D spending in fiscal 2014 […]
Strong Clinical Demand for Affymetrix Affymetrix third quarter sales slipped 0.6% to $86.5 million but grew 3.4% excluding currency due to strong clinical demand, increased licensing revenue and further adoption in pharmaceutical markets. Overall, Consumables sales grew 2.7%, roughly 7% excluding currency, to account for 88% of revenues. Instrument sales declined 1.0% but grew in […]
Agilent Maintains Cautious Outlook Agilent Technologies’ fiscal fourth quarter revenues ending October 31 fell 0.8% to $1.04 billion, in line with expectations. Excluding currency and divestments, which reduced revenue growth by 6.4% and 0.6%, respectively, organic sales rose 6.2%. All sales figures are organic. Sales to analytical lab markets grew roughly 6% to account for […]
With a slight uptick in inflation, improved manufacturing and strong employment reported in November, the US Federal Reserve has now targeted the beginning of December for a potential rate hike. In addition, US third quarter GDP growth was revised upwards 60 basis points to 2.1% due to increased inventory buildup. However, the stronger inventories may […]
Pfaffikon, Switzerland 11/20/15; Stockholm, Sweden 11/20/15—Technology firm Oerlikon has agreed to sell its Leybold Vacuum business to industrial tools provider Atlas Copco for CHF 525 million ($515 million = CHF 1.02 = $1) in cash. The business generated annual revenues of CHF 390 million ($415 million = CHF 0.94 = $1) as of June 30 […]
For major publicly held instrument and lab product firms, calendar year third quarter organic sales advanced at a steady pace, driven by demand from biopharmaceutical markets, especially in the US, Europe and Asia. For the businesses in the Life Science and Analytical Instrument Indexes (see page 9), as well as Becton, Dickinson Biosciences, combined sales […]
The EU’s 2016 budget was adopted by the European Parliament on November 25, restoring funding for the EU’s Horizon 2020 program that had been cut in the draft budget. Horizon 2020 is the EU’s primary mechanism for funding scientific research, with an estimated $103.4 billion budget from 2014 to 2020 (see IBO 12/31/13). Compared to […]
Bruker Tops Estimates Bruker Scientific Instruments (BSI) delivered robust third quarter organic sales, led by increased government funding, strong NMR and MS sales, and timing of orders. Excluding currency and divestments, sales rose 9.2% to $366.6 million to account for 93% of revenues. System and aftermarket revenues grew roughly 7% and 16% organically to make […]
To promote research in fields in which India relies largely on technology from abroad, the country’s government will launch a funding opportunity on November 5 of INR 1,000 crore ($154 million). An interministerial group will review projects and proposals submitted by India’s research and technology institutes for the awards. The IMPRINT funding mechanism will support […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
